Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NO AD: GTN for Autonomic Dysreflexia in SCI
NCT05635851Phase 2Not yet recruiting
- Sponsor
- Simon Fraser University
- Start
- Dec 2026
- Primary completion
- Feb 2028
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of nitroglycerin in autonomic dysreflexia (AD) (2 arms), sponsored by Simon Fraser University. Primary endpoint: Blood pressure change during bowel care. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
nitroglycerin
03
Conditions
autonomic dysreflexia (AD)
Beyond the preview
Go deeper on NCT05635851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05635851.